Viking Therapeutics, Inc. (VKTX)
37.53
+0.25
(+0.67%)
USD |
NASDAQ |
Dec 10, 16:00
37.46
-0.07
(-0.19%)
After-Hours: 20:00
Viking Therapeutics Total Liabilities (Quarterly): 26.38M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly & Co. | 91.08B |
| Pfizer Inc. | 115.64B |
| Amgen, Inc. | 80.52B |
| Altimmune, Inc. | 32.85M |
| Terns Pharmaceuticals, Inc. | 17.58M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 739.42M |
| Shareholders Equity (Quarterly) | 713.03M |
| Debt to Equity Ratio | 0.0011 |
| Current Ratio | 28.34 |
| Net Debt Paydown Yield | 0.00% |